"10.1371_journal.pone.0019138","plos one","2011-05-06T00:00:00Z","Ellen Iacobaeus; Petra Amoudruz; Mikael Ström; Mohsen Khademi; Lou Brundin; Jan Hillert; Ingrid Kockum; Vivianne Malmström; Tomas Olsson; Emma Tham; Fredrik Piehl","Department of Clinical Neuroscience, Neuroimmunology Unit, Karolinska Institute Solna, Center for Molecular Medicine, Stockholm, Sweden; Department of Medicine, Rheumatology Unit, Karolinska Institute Solna, Center for Molecular Medicine, Stockholm, Sweden; Department of Clinical Neuroscience, The Multiple Sclerosis Research Group, Karolinska Institute Solna, Center for Molecular Medicine, Stockholm, Sweden; Department of Clinical Genetics, L5:03, Karolinska University Hospital, Solna, Sweden","Conceived and designed the experiments: EI FP TO ET MK IK JH. Performed the experiments: EI MS MK PA VM. Analyzed the data: EI FP ET MS MK IK PA VM. Contributed reagents/materials/analysis tools: TO JH LB VM. Wrote the paper: EI FP ET MK.","Tomas Olsson and Jan Hillert have received personal compensation for consultancy or lecture fees from BiogenIdec, MerckSerono, SanofiAventis, BayerSchering and Novartis. BiogenIdec Sweden AB provided an unrestricted grant for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. Fredrik Piehl, Ellen Iacobaeus, Emma Tham, Mikael Ström, Mohsen Khademi, Ingrid Kockum, Vivianne Malmström and Petra Amoudruz have no conflicts to declare.","2011","05","Ellen Iacobaeus","EI",11,TRUE,7,5,8,4,TRUE,TRUE,FALSE,0,NA,FALSE
